通城PLC编程培训学校再谈PLC Systems Reports Fourth Quarter 2007 Results

Fourth quarter 2007 total revenues were $1,248,000 compared with $1,747,000 in the fourth quarter of 2006. The net loss for the fourth quarter of 2007 was $819,000, or $0.03 per diluted share, compared to net income of $36,000, or $0.00 per diluted share, in the fourth quarter of 2006. For the full year 2007, PLC reported total revenues of $6,004,000 compared to $7,146,000 in 2006. The net loss for 2007 was $2,367,000, or $0.08 per diluted share, compared to net income of $1,319,000, or $0.04 per diluted share, in 2006, a period that also included a $1.4 million gain on the sale of PLC''s Optiwave disposable manufacturing rights to Edwards Lifesciences Corporation. Cash and short term investments at the end of the fourth quarter of 2007 totaled $8,060,000, down from $10,034,000 at the end of December 2006.

Mark R. Tauscher, president and chief executive officer of PLC Systems, Inc., stated, "We are very pleased with our substantial progress on our RenalGuard(TM) product development efforts in the fourth quarter of 2007. We successfully concluded our pilot clinical safety trial after enrolling 23 patients, and we secured a CE Mark for RenalGuard in Europe. We recently announced that we had filed an IDE supplement with the U.S. Food & Drug Administration to begin our U.S. multi-center pivotal trial to study the effectiveness of RenalGuard in reducing the incidence of Contrast-Induced Nephropathy (CIN). This pivotal clinical trial is expected to continue through 2009. Meanwhile, we are awaiting approval of the clinical study utilizing our RenalGuard System(TM) and RenalGuard Therapy(TM) at the Centro Cardiologico Monzino (CCM- University of Milan) in Milan, Italy. We anticipate that this study will greatly increase the visibility of our RenalGuard System and RenalGuard Therapy throughout the European Union, and will be instrumental in supporting our initial limited launch of the product in Italy starting later this quarter."

Mr. Tauscher added, "At the same time, 2007 was a year of transition for our core TMR business. In March 2007, we began a new relationship with Novadaq Technologies, Inc., replacing Edwards Lifesciences as our exclusive U.S. TMR distribution partner. We had anticipated the transition would take some time, and our expectations were correct. We are pleased that fourth quarter 2007 HL2 system sales and TMR kit shipments from Novadaq to U.S. hospitals increased sequentially from the third quarter of 2007. We believe that Novadaq is working hard to build this business for the long-term, since the synergies between our TMR system and Novadaq''s SPY? Imaging Technology are strong. Those synergies, plus the increased experience of Novadaq''s sales force with the TMR technology, we hope will lead to improved performance for this business in 2008."

During the fourth quarter of 2007, PLC shipped seven CO2 Heart Lasers (HL2) to U.S. hospitals through Novadaq, compared to six HL2s shipped in the fourth quarter of 2006. Three of the shipments in the fourth quarter of 2007 were new HL2 lasers and four were redeployed units. PLC ended the fourth quarter of 2007 with 169 HL2 CO2 Heart Lasers located at heart centers throughout the U.S. During the fourth quarter of 2007, a total of 372 disposable TMR kits were shipped, all to hospitals in the U.S., by Novadaq. In comparison, a total of 313 and 466 disposable TMR kits were delivered to hospitals in the U.S. during the third quarter of 2007 and the fourth quarter of 2006, respectively.

Conference Call

PLC Systems will host a conference call today, March 5, 2008, at 11:00 a.m. ET to discuss these matters. The call may be joined by dialing (888) 713-4205, or internationally, (617) 213-4862, at least five minutes prior to the start of the call. The passcode is 25917459. A live webcast of the call will be accessible at the investor relations section of the Company''s website at . An archived webcast of the conference call will be available beginning one hour after the completion of the call in the same location. A replay of the call can also be accessed telephonically by dialing 888-286-8010, or internationally 617-801-6888, using passcode 90665991, from 1:00 p.m. ET on March 5, 2008 through midnight on March 12, 2008.

About PLC Systems Inc.

PLC Systems Inc. is a medical technology company specializing in innovative technologies for the cardiac and vascular markets. Headquartered in Franklin, Mass., PLC pioneered the CO2 Heart Laser System, which cardiac surgeons use to perform CO2 transmyocardial revascularization (TMR) to alleviate symptoms of severe angina. CO2 TMR offers a treatment option for angina patients who suffer from severe coronary artery disease. The CO2 Heart Laser is the world''s first TMR angina relief device cleared for commercial distribution by both the U.S. Food and Drug Administration and Japanese Ministry of Health, Labor and Welfare, and to obtain a CE Mark for European distribution.湖南阳光PLC编程培训学校,常年面向通城地区招生,零基础实战教学,小班授课,教学质量更有保证,全程创业指导。25年PLC编程技术沉淀,80%实操+20%理论,实战+实例+实践的教学方法授课.为通城地区的PLC编程学员提供广阔的就业机会。-通城PLC编程培训学校